Brokerages Set Integer Holdings Co. (NYSE:ITGR) Price Target at $133.86

Shares of Integer Holdings Co. (NYSE:ITGR) have been assigned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $133.86.

ITGR has been the subject of several recent analyst reports. Benchmark restated a “buy” rating and set a $130.00 price objective on shares of Integer in a research report on Friday, August 2nd. Oppenheimer initiated coverage on shares of Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price objective for the company.

Integer Stock Down 1.7 %

Shares of Integer stock opened at $129.19 on Wednesday. Integer has a 52-week low of $69.40 and a 52-week high of $131.87. The company has a 50 day moving average of $122.98 and a 200 day moving average of $118.60. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $4.33 billion, a P/E ratio of 44.70, a P/E/G ratio of 1.81 and a beta of 1.09.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.06. The business had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 EPS. As a group, research analysts forecast that Integer will post 5.31 EPS for the current fiscal year.

Insider Activity at Integer

In related news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integer

Institutional investors have recently bought and sold shares of the company. Quest Partners LLC increased its stake in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the period. GAMMA Investing LLC increased its stake in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares during the period. Principal Securities Inc. acquired a new position in Integer in the 4th quarter valued at $67,000. Headlands Technologies LLC acquired a new position in Integer in the 1st quarter valued at $106,000. Finally, Innealta Capital LLC acquired a new position in Integer in the 2nd quarter valued at $110,000. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.